Alan Franklin

Company: ForwardVue Pharma

Job title: Chief Executive Officer

Seminars:

Carboxyamidotriazole Delivers Potent Anti-Angiogenic, Safe, and Durable Treatment For Neovascular Ocular Disease 3:30 pm

Carboxyamidotriazole has an extensive human safety profile after systemic administration Carboxyamidotriazole is a novel chemical entity for ocular disease Carboxyamidotriazole can be durably administered and is effective in multiple pre-clinical models of ocular neovascular diseaseRead more

day: Day Two